HAL (France)open access
Hospital-Compounded Birabresib Capsules for NUT Carcinoma: A Quality- and Risk-Based CMC Strategy
Stability program, 0, Quality & risk-based CMC framework, 1, Non-GMP material qualification, Capsule compounding
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 153736
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.